| Year |
Citation |
Score |
| 2016 |
Wilkins HM, Koppel S, Carl SM, Ramanujan S, Weidling I, Michaelis ML, Michaelis EK, Swerdlow RH. Oxaloacetate Enhances Neuronal Cell Bioenergetic Fluxes and Infrastructure. Journal of Neurochemistry. PMID 26811028 DOI: 10.1111/Jnc.13545 |
0.481 |
|
| 2016 |
Wilkins HM, Weidling I, Carl SM, Ramanujan S, Weber SG, Swerdlow RH. P4-067: Influence of Cell Bioenergetics on App Processing Alzheimer's & Dementia. 12: P1039-P1039. DOI: 10.1016/J.Jalz.2016.06.2157 |
0.467 |
|
| 2015 |
Wilkins HM, Carl SM, Weber SG, Ramanujan SA, Festoff BW, Linseman DA, Swerdlow RH. Mitochondrial lysates induce inflammation and Alzheimer's disease-relevant changes in microglial and neuronal cells. Journal of Alzheimer's Disease : Jad. 45: 305-18. PMID 25537010 DOI: 10.3233/Jad-142334 |
0.538 |
|
| 2015 |
Selfridge JE, Wilkins HM, E L, Carl SM, Koppel S, Funk E, Fields T, Lu J, Tang EP, Slawson C, Wang W, Zhu H, Swerdlow RH. Effect of one month duration ketogenic and non-ketogenic high fat diets on mouse brain bioenergetic infrastructure. Journal of Bioenergetics and Biomembranes. 47: 1-11. PMID 25104046 DOI: 10.1007/S10863-014-9570-Z |
0.44 |
|
| 2015 |
Wilkins HM, Carl SM, Ramanujan S, Weber SG, Swerdlow RH. P3-023: Influence of mitochondrial function and cell bioenergetics on app processing Alzheimer's & Dementia. 11: P628-P628. DOI: 10.1016/J.Jalz.2015.06.889 |
0.525 |
|
| 2014 |
Wilkins HM, Carl SM, Swerdlow RH. Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies. Redox Biology. 2: 619-631. PMID 25460729 DOI: 10.1016/J.Redox.2014.03.006 |
0.457 |
|
| 2014 |
Wilkins HM, Carl SM, Greenlief AC, Festoff BW, Swerdlow RH. Bioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connection. Frontiers in Aging Neuroscience. 6: 311. PMID 25426068 DOI: 10.3389/Fnagi.2014.00311 |
0.419 |
|
| 2014 |
Wilkins HM, Harris JL, Carl SM, E L, Lu J, Eva Selfridge J, Roy N, Hutfles L, Koppel S, Morris J, Burns JM, Michaelis ML, Michaelis EK, Brooks WM, Swerdlow RH. Oxaloacetate activates brain mitochondrial biogenesis, enhances the insulin pathway, reduces inflammation and stimulates neurogenesis. Human Molecular Genetics. 23: 6528-41. PMID 25027327 DOI: 10.1093/Hmg/Ddu371 |
0.517 |
|
| 2014 |
Wilkins HM, Swerdlow RH, Carl S, Harris J, Lu J, Koppel S, E L, Selfridge E, Hutfles L, Roy N, Burns JM, Brooks WM, Michaelis M, Michaelis E. P4-199: IMPACT OF OXALOACETATE ON BRAIN BIOENERGETIC INFRASTRUCTURES, NEUROGENESIS, AND INFLAMMATION Alzheimer's & Dementia. 10: P861-P861. DOI: 10.1016/J.Jalz.2014.05.1716 |
0.467 |
|
| Show low-probability matches. |